CD40 and renal cell adenocarcinoma: CD40/CD40L engagement on RCC cells has been observed to trigger ERK, c-Jun N-terminal kinase (JNK), and p38 MAPK, and to recruit NFAT, thereby driving RCC cell migration (Pontrelli et al., 2021).